Insider Transactions in Q3 2021 at Abiomed Inc (ABMD)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.07%
|
-
|
|
Sep 30
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36
+0.02%
|
-
|
|
Aug 23
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Open market or private sale
|
Direct |
3,492
-1.62%
|
$1,222,200
$350.0 P/Share
|
|
Aug 23
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,492
+1.6%
|
$80,316
$23.15 P/Share
|
|
Aug 19
2021
|
Martin P Sutter |
SELL
Bona fide gift
|
Direct |
1,000
-0.62%
|
-
|
|
Aug 18
2021
|
Paul Thomas |
SELL
Open market or private sale
|
Direct |
663
-8.76%
|
$218,790
$330.77 P/Share
|
|
Aug 18
2021
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
3,750
-0.46%
|
$1,248,750
$333.28 P/Share
|
|
Aug 17
2021
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
3,750
-0.32%
|
$1,222,500
$326.27 P/Share
|
|
Aug 12
2021
|
Chris Van Gorder |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-4.51%
|
$106,227
$319.88 P/Share
|
|
Aug 12
2021
|
Eric A Md Rose |
SELL
Payment of exercise price or tax liability
|
Direct |
265
-1.76%
|
$84,535
$319.88 P/Share
|
|
Aug 12
2021
|
Paul Thomas |
SELL
Payment of exercise price or tax liability
|
Direct |
245
-3.13%
|
$78,155
$319.88 P/Share
|
|
Aug 12
2021
|
Martin P Sutter |
SELL
Payment of exercise price or tax liability
|
Direct |
245
-0.14%
|
$78,155
$319.88 P/Share
|
|
Aug 12
2021
|
Dorothy E Puhy |
SELL
Payment of exercise price or tax liability
|
Direct |
279
-7.99%
|
$89,001
$319.88 P/Share
|
|
Aug 11
2021
|
Paula A Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
625
+31.77%
|
-
|
|
Aug 11
2021
|
Myron L Rolle |
BUY
Grant, award, or other acquisition
|
Direct |
625
+30.64%
|
-
|
|
Aug 11
2021
|
Chris Van Gorder |
BUY
Grant, award, or other acquisition
|
Direct |
625
+7.81%
|
-
|
|
Aug 11
2021
|
Jeannine M Rivet |
BUY
Grant, award, or other acquisition
|
Direct |
625
+6.31%
|
-
|
|
Aug 11
2021
|
Eric A Md Rose |
BUY
Grant, award, or other acquisition
|
Direct |
625
+3.97%
|
-
|
|
Aug 11
2021
|
Paul Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
625
+7.4%
|
-
|
|
Aug 11
2021
|
Martin P Sutter |
BUY
Grant, award, or other acquisition
|
Direct |
625
+0.37%
|
-
|
|
Aug 11
2021
|
Dorothy E Puhy |
BUY
Grant, award, or other acquisition
|
Direct |
625
+15.17%
|
-
|
|
Aug 09
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Open market or private sale
|
Direct |
7,037
-3.22%
|
$2,462,950
$350.0 P/Share
|
|
Aug 09
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,037
+3.12%
|
$161,851
$23.15 P/Share
|
|
Aug 06
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Open market or private sale
|
Direct |
24,471
-10.36%
|
$8,564,850
$350.0 P/Share
|
|
Aug 06
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,471
+9.39%
|
$562,833
$23.15 P/Share
|
|
Aug 05
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.56%
|
$8,575,000
$343.34 P/Share
|
|
Aug 05
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+9.56%
|
$575,000
$23.15 P/Share
|
|
Jul 23
2021
|
Marc A Began VP & GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-1.77%
|
$34,238
$323.54 P/Share
|